0000000000527271

AUTHOR

A. Russo

showing 78 related works from this author

Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers

2015

Background: Long Non-coding RNAs (lncRNA) are emerging as essential regulators of genetic and epigenetic networks, and their deregulation may underlie complex diseases, such as carcinogenesis. Several studies have described lncRNAs alterations in patients with solid tumors. In particular, in Gastrointestinal Stromal Tumors (GIST), upregulation of HOTAIR has been associated with aggressiveness, metastasis, and poor patients’ survival. In order to gain more detailed insight on the molecular role of lncRNAs in GIST, we analyzed in vivo the expression levels of lncRNAs H19 and MALAT1 in surgically resected patients. Material and Methods: The expression of the lnc-RNAs H19 and MALAT1 was evaluat…

Long non coding RNAs Gastrointestinal Stromal Tumors prognostic/predictive biomarkers
researchProduct

P1.13-16 The Diagnostic Accuracy of Circulating Tumor DNA for the Detection of EGFR-T790M Mutation in NSCLC: A Systematic Review and Meta-Analysis

2018

0301 basic medicinePulmonary and Respiratory Medicinebusiness.industryDiagnostic accuracyEGFR T790M03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyCirculating tumor DNA030220 oncology & carcinogenesisMeta-analysisMutation (genetic algorithm)Cancer researchMedicinebusinessJournal of Thoracic Oncology
researchProduct

BRCA1 missense variants of uncertain clinical significance in unaffected and breast/ovarian cancer of the Sicilian population.

2006

n
researchProduct

Metabolic pathways in Microbispora sp. ATCC-PTA 5024, producer of NAI-107 lantibiotic

2014

Microbispora sp. ATCC-PTA 5024 lantibioticNAI-107 2D-DIGESettore BIO/19 - Microbiologia Generale
researchProduct

EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE

2010

Background: MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of different genes, including genes involved in cancer progression, angiogenesis and metastasis. Thrombospondin-1 (TSP-1) has been shown to contrast angiogenesis in vivo. TSP-1 expression levels are inversely correlated with tumor vascularity and metastasis in colon cancer. Bio-informatic statistical analysis indicated that TSP-1 is hypothetical target of miR-21, miR-182, overexpressed in CRC, and let-7i which expression is down-regulated in this tumor. In this work we investigated whether TSP-1 expression could be regulated by miR-21, mir-182 and let-7i in HT29 colon cancer cell line. Methods: To investig…

Colon cancer cell line microRNA
researchProduct

P2.04-10 Early Monitoring of Blood Biomarkers to Predict Nivolumab Efficacy in NSCLC Patients

2018

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologyBlood biomarkersbusiness.industryInternal medicinemedicineNivolumabbusinessJournal of Thoracic Oncology
researchProduct

Phase 3 randomized study of adjuvant anastrozole (A), exemestane (E), or letrozole (L) with or without tamoxifen (T) in postmenopausal women with hor…

2017

515 Background: Uncertainty still exists regarding the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors (AI) and no trial has ever compared all the three AI. Methods: FATA-GIM3 is a multicenter, open label, 2x3 factorial phase 3 randomized study of adjuvant A, E and L upfront (UP - for 5 years) or sequentially (SEQ - for 3 years after 2 years of T) in postmenopausal HR breast cancer pts. Two comparisons were planned: UP vs SEQ and A vs E vs L. DFS (including local or distant relapse, second breast or non-breast cancer, DCIS and death, whichever came first) was the primary end-point; 2% at 5 yrs (corresponding to a HR of 0.79) was defined as the minimum diff…

Hormone ResponsiveOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentAnastrozolelaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBreast cancerRandomized controlled trialExemestanelawInternal medicinemedicineData monitoring committeeGynecologybusiness.industryLetrozoleCancerHematologymedicine.diseaseOncologychemistry030220 oncology & carcinogenesisbusinessAdjuvantTamoxifen030215 immunologymedicine.drugJournal of Clinical Oncology
researchProduct

The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSC…

2020

Background The role of tumor mutational burden (TMB) is still debated for selecting advanced non-oncogene addicted non-small-cell lung cancer (NSCLC) patients who might benefit from immune checkpoint inhibitors (ICIs). Of note, TMB failed to predict a benefit in overall survival (OS) among such patients. Materials and methods The purpose of this meta-analysis was to compare efficacy outcomes among first-line immune-oncology (IO) agents versus standard platinum-based chemotherapy (CT) within two subgroups (TMB-low and TMB-high on either tissue or blood). We collected hazard ratios (HRs) to evaluate the association for progression-free survival (PFS) and OS, with the relative 95% confidence i…

OncologyCancer Researchmedicine.medical_specialtyLung NeoplasmsSettore MED/06 - Oncologia MedicaPopulationnon-small cell lung cancer (NSCLC)ReviewNSCLCmeta-analysilaw.inventionRandomized controlled triallawCarcinoma Non-Small-Cell LungStatistical significanceInternal medicineICIs meta-analysis NSCLC prognostic TMBHumansMedicineICIsProspective StudiesLung cancereducationRandomized Controlled Trials as Topiceducation.field_of_studyICITMBbusiness.industryHazard ratioPrognosismedicine.diseasemeta-analysisClinical Trials Phase III as TopicOncologyRelative riskMeta-analysisbusinessprognosticESMO Open
researchProduct

Nab-paclitaxel (nab-P) in metastatic breast cancer (MBC) in elderly patients: A real life setting (NEREIDE study)

2018

Oncologymedicine.medical_specialtyOncologyPaclitaxel protein-boundbusiness.industryInternal medicineMedicineHematologybusinessReal life settingmedicine.diseaseMetastatic breast cancerNab-paclitaxelAnnals of Oncology
researchProduct

71P Role of radiomics in predicting molecular phenotypes of female breast cancer

2020

Oncologymedicine.medical_specialtyOncologyRadiomicsbusiness.industryInternal medicinemedicineHematologybusinessPhenotypeFemale breast cancerAnnals of Oncology
researchProduct

TOWARD A DESIGN METHOD FOR METAL-COMPOSITE CO-CURED JOINT BASED ON THE G-SIFs

2013

Abstract In this work, a systematic study of the singular stress field in the zone where the interface intersects the free edge surfaces of bonded metal-composite co-cured joints, has been performed. The obtained theoretical, numerical and experimental results have permitted to detect the relationships between the joint configuration and the singular stress field, as well as to implement a new design method based on the so called generalised stress intensity factors. Such a proposed method allows the user to predict the static strength of a generic metal-composite co-cured joint, vs. the main influence parameters as the elastic modulus of the coupled materials, the overlap length, the taper…

Polymer-matrix composites (PMCs)Work (thermodynamics)Materials sciencebusiness.industryMechanical EngineeringComposite numberStructural engineeringIndustrial and Manufacturing EngineeringJoints/joiningStress fieldAnalytical modelingSettore ING-IND/14 - Progettazione Meccanica E Costruzione Di MacchineLap jointMechanics of MaterialsCeramics and CompositesStrengthComposite materialbusinessElastic modulusJoint (geology)Stress intensity factorReliability (statistics)
researchProduct

Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)…

2021

Pancreatic cancer (PC) is a common cause of cancer-related death, due to difficulties in detecting early-stage disease, to its aggressive behaviour, and to poor response to systemic therapy. Therefore, developing strategies for early diagnosis of resectable PC is critical for improving survival. Diabetes mellitus is another major public health problem worldwide. Furthermore, diabetes can represent both a risk factor and a consequence of PC: nowadays, the relationship between these two diseases is considered a high priority for research. New-onset diabetes can be an early manifestation of PC, especially in a thin adult without a family history of diabetes. However, even if targeted screening…

Cancer Researchmedicine.medical_specialtyConsensusReviewDiseaseMedical OncologySystemic therapyNOconsensus; diabetes; early diagnosis; hyperglycaemia; pancreatic carcinoma; Consensus; Humans; Medical Oncology; Diabetes Mellitus; Pancreatic Neoplasms; PhysiciansDiabetes mellitusPancreatic cancerPhysiciansmedicineDiabetes MellitusHumansFamily historyRisk factorLS4_3Intensive care medicinediabetes pancreatic carcinoma early diagnosis consensus hyperglycaemiadiabetespancreatic carcinomabusiness.industryPublic healthmedicine.diseasePancreatic NeoplasmsOncologyPosition paperbusinesshyperglycaemiaearly diagnosis
researchProduct

Predictive factors of response to Sunitinib in metastatic Gastrointestinal Stromal Tumors (mGISTs): A retrospective analysis

2017

Oncologymedicine.medical_specialtyStromal cellOncologybusiness.industrySunitinibInternal medicinemedicineRetrospective analysisHematologybusinessmedicine.drugAnnals of Oncology
researchProduct

Elucidating the molecular physiology of lantibiotic NAI-107 production in Microbispora ATCC-PTA-5024.

2016

Background The filamentous actinomycete Microbispora ATCC-PTA-5024 produces the lantibiotic NAI-107, which is an antibiotic peptide effective against multidrug-resistant Gram-positive bacteria. In actinomycetes, antibiotic production is often associated with a physiological differentiation program controlled by a complex regulatory and metabolic network that may be elucidated by the integration of genomic, proteomic and bioinformatic tools. Accordingly, an extensive evaluation of the proteomic changes associated with NAI-107 production was performed on Microbispora ATCC-PTA-5024 by combining two-dimensional difference in gel electrophoresis, mass spectrometry and gene ontology approaches. R…

0301 basic medicineProteomicsfood.ingredientMetabolic networkATP-binding cassette transporterActinomycetes Antibiotic production Differential proteomics 2D-DIGE and mass spectrometry Metabolic pathways Regulatory network Molecular and cellular functionsBiologyBioinformaticsProteomicsGram-Positive Bacteria03 medical and health sciencesfoodBacteriocinsActinomycetesGenetics2D-DIGE and mass spectrometryDifferential proteomics2. Zero hungerGel electrophoresisLipid metabolismRegulatory networkbiology.organism_classificationDrug Resistance MultipleAnti-Bacterial AgentsActinobacteriaMetabolic pathway030104 developmental biologyBiochemistryMicrobisporaMetabolic pathwaysATP-Binding Cassette TransportersAntibiotic productionPeptidesBacteriaMolecular and cellular functionsBiotechnologyResearch ArticleBMC genomics
researchProduct

1543P Gemcitabine in classic Kaposi’s sarcoma: A pilot study

2021

Oncologymedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineClassic Kaposi's sarcomaHematologybusinessGemcitabinemedicine.drugAnnals of Oncology
researchProduct

502P Impact of different selection approaches for identifying Lynch syndrome-related colorectal cancer patients

2021

Oncologymedicine.medical_specialtyOncologybusiness.industryColorectal cancerInternal medicineMedicineHematologybusinessmedicine.diseaseSelection (genetic algorithm)Lynch syndromeAnnals of Oncology
researchProduct

53P Role of immune biomarkers in evaluating predictive and prognostic value in advanced stage HER2 positive breast cancer

2020

Oncologymedicine.medical_specialtyImmune systemOncologybusiness.industryInternal medicineHER2 Positive Breast CancerAdvanced stageMedicineHematologybusinessValue (mathematics)Annals of Oncology
researchProduct

Weekly paclitaxel and Pegylated liposomal doxorubicin as first line treatment in metastatic breast cancer patients

2004

Background: Paclitaxel-Doxorubicin combination chemotherapy is highly active in metastatic breast cancer patients (pts) but may be cardiotoxic in a small percentage of cases. PLD is a new formulation of Doxorubicin with significant reduced cardiac toxicity and for this reason PLD can be given safe in elderly patients with cardiac risk factors or in younger patients with prior exposure to anthracycline-containing regimens. The main side effect of PLD is Hand-Foot syndrome but when given in intervals not below 4 weeks and with a dose intensity not exceeding 10 mg/sqm per week, this side effects is clearly reduced. Methods: : We carried out a phase 2 study to verify the activity of P 70 mg/sm …

Cancer ResearchOncology
researchProduct

Hereditary common cancers: molecular and clinical genetics.

2001

This review focuses on the functional role and structural features of the genes involved in common hereditary cancers. Most of these tumors are sporadic and the genetic alterations responsible for their genesis take place over several cell generations; nevertheless, 5 to 10% of the human tumors are hereditary, with a rapid development. Cancer susceptibility genes have been classified as "gatekeepers" (e.g. RB1, ki-ras) and "caretakers" (e.g. hMLH1 and hMSH2, BRCA1). The first step in identifying individuals at high risk of developing a specific inherited form of cancer, and who should therefore undergo genetic tests, is the detailed construction of family history (an accurate cancer family …

MaleModels GeneticSettore MED/06 - Oncologia MedicaBRCA geneRisk AssessmentHereditary cancerPedigreeAPC geneNeoplasmsBiomarkers TumorAnimalsHumansFemaleGenes Tumor SuppressorGenetic Predisposition to DiseaseMMR genesAnticancer research
researchProduct

1281P The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lun…

2020

Oncologymedicine.medical_specialtyOncogenebusiness.industrynon-small cell lung cancer (NSCLC)Hematologymedicine.diseaselaw.inventionFirst line treatmentOncologyRandomized controlled triallawInternal medicineMeta-analysismedicinebusinessAnnals of Oncology
researchProduct

Metastatic site location may influence the diagnostic accuracy of plasma EGFR-mutation testing in NSCLC: A pooled analysis

2017

Oncologymedicine.medical_specialtyPooled analysisOncologySite locationEgfr mutationbusiness.industryInternal medicinemedicineDiagnostic accuracyHematologybusinessAnnals of Oncology
researchProduct

94P ESCAT ranking of genomic alterations collected in the Italian Registry of Actionable Mutations

2021

Oncologybusiness.industryMedicineHematologyComputational biologybusinessRanking (information retrieval)Annals of Oncology
researchProduct

Could starvation minimize chemotherapy-induced toxicities?

2008

chemotherapytoxicitiesstarvation
researchProduct

Evaluation of the effects of a program of "homework" for the maintenance of the outcomes achieved at three months after discharge from integrated hom…

2010

When the rehabilitation treatment performed in the acute phase of illness is over, in our experience, the majority of patients do not continue the rehabilitation exercises thus risking a reduction in the ability retrieved and increasing disability. So despite the achievements with the rehabilitation treatment at home, discharge the patients could produce a worsening of their disability. In order to encourage patients to continue physical exercise after discharge from integrated home care, we proposed a personalized exercise program to be carried out at home. We evaluated after three months effectiveness in order to sustain the degree of self-sufficiency and the health reached at discharge

Personalized exerciseRehabilitationHomeworkSettore MED/42 - Igiene Generale E ApplicataHome care
researchProduct

Correction: Circulating insulin-like growth factor-1: A new clue in the pathogenesis of age-related macular degeneration [Aging (Albany NY), 10 (2018…

2018

circulating insulin like

correction
researchProduct

Regorafenib for previously treated metastatic colorectal cancer (mCRC): results from 683 Italian patients treated in the open-label phase IIIB CONSIG…

2015

Oncologymedicine.medical_specialtybusiness.industryColorectal cancerHematologymedicine.diseasechemistry.chemical_compoundOncologychemistryInternal medicineRegorafenibMedicineOpen labelbusinessPreviously treatedAnnals of Oncology
researchProduct

P33.15 TMB in the First-Line Setting of NSCLC: A Systematic Review with Indirect Comparisons Between PD-1 and PD-L1 Inhibitors

2021

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologybiologybusiness.industryPD-L1First lineInternal medicinemedicinebiology.proteinbusinessJournal of Thoracic Oncology
researchProduct

Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters

1994

Cathepsin D, B and L activity levels were determined in colorectal cancer and correlated with a number of biological and clinical parameters. Our studies have evidenced significant higher activity levels of these lysosomal enzymes in tumor cytosol compared to paired normal mucosa as well as an evident increase of tumor specific cathepsin D activity in Dukes' stage A tumors compared to later stages (B, C and D). Furthermore, significant higher cathepsin B and L activity levels were observed in Dukes' stage A compared to Dukes' stage D tumors while significant higher cathepsin B activity levels were observed in tumors ≤5 cm than in those >5 cm as well as in moderately differentiated tumors…

Tumor progression.Cathepsin LMetastasiLysosomal proteinaseCathepsin DColorectal cancerCathepsin B
researchProduct

Finding the right biomarker for renal cell carcinoma (RCC): Nivolumab treatment induces the expression of specific peripheral lymphocyte microRNAs in…

2019

Abstract Background The variability of clinical response to immune checkpoint inhibitors in RCC patients makes necessary the discovery of predictive biomarkers for patient selection. Emerging evidence has revealed a multitude of silenced genes and deregulated signalling pathways. These findings point towards extensive microRNAs (miRNAs) regulation and imply epigenetic reprogramming as a key feature of RCC. The aim of this study was to analyze the peripheral lymphocyte miRNA expression profile in metastatic RCC patients undergoing nivolumab treatment, to identify a lymphocyte miRNA signature specifically expressed in patients with partial or complete response (RP; RC) >12 months. Methods miR…

0301 basic medicinebiologybusiness.industryMicroarray analysis techniquesLymphocyteHematologymedicine.disease03 medical and health sciences030104 developmental biology0302 clinical medicinemedicine.anatomical_structureOncologyRenal cell carcinoma030220 oncology & carcinogenesismicroRNAmedicinebiology.proteinCancer researchPTENBiomarker (medicine)NivolumabbusinessPI3K/AKT/mTOR pathwayAnnals of Oncology
researchProduct

Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family.

2006

researchProduct

The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Pl…

2021

Background: The ISTH Bleeding Assessment Tool (ISTH-BAT) has been validated for clinical screening of suspected von Willebrand disease (VWD) and for bleeding prediction. Recently it has been validated for subjects with inherited platelet disorders (IPD) (BAT-VAL study). Objectives: To determine whether the ISTH-BAT bleeding score (BS) predicts subsequent bleeding events requiring treatment in IPD patients. Methods: Patients with IPD, type 1 VWD (VWD-1) and age- and sex-matched healthy controls enrolled in the BAT-VAL study were prospectively followed-up for 2 years and bleeding episodes requiring treatment were recorded. Results: Of the 1098 subjects initially enrolled, 955 were followed-up…

medicine.medical_specialtyanimal structuresmild&#8208Platelet Function TestsPlatelet disorderinherited platelet disorderHemorrhage030204 cardiovascular system & hematologyHemorrhage/diagnosis03 medical and health sciences0302 clinical medicineVon Willebrand factorhemic and lymphatic diseasesInternal medicinevon Willebrand FactorVon Willebrand diseaseMedicineHumansPlateletBleeding prediction Bleeding score Blood platelet disorders Child Communication Hemorrhage Humans Inherited platelet disorders Mild-moderate bleeding disorders Platelet Function Tests von Willebrand diseases von Willebrand FactorChildBlood Platelet Disordersddc:616mild-moderate bleeding disordersbiologybusiness.industrymild-moderate bleeding disorderIncidence (epidemiology)CommunicationSettore MED/09 - MEDICINA INTERNAbleeding predictionvon Willebrand Diseases/diagnosis/genetics[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHematologymedicine.diseaseBlood Platelet Disorders/diagnosis/genetics3. Good healthbleeding scoreInstitutional repositoryvon Willebrand Diseasesmoderate bleeding disordersinherited platelet disordersQuartilebiology.proteinBlood Platelet Disordersvon Willebrand diseasebusinessJournal of thrombosis and haemostasis : JTHREFERENCES
researchProduct

A Ferrite Tubular Linear Permanent Magnet Generator (FTLPMG) analysis and design

2014

Several linear synchronous generators for the exploitation of sea wave energy have been proposed. Such machines do not require reactive power for the magnetization since they use permanent magnets for the excitation. The use of permanent magnets in a rough environment such as the marine environment may be a very weak point in the application of these kind of devices. In order to overcome this difficulty, the authors in this paper propose a linear synchronous electrical generator. Its excitation uses ferrites as suitable solutions to extract energy from sea waves. This paper describes the analysis and design of an improved axially magnetized tubular permanent-magnet machine in which several …

Sea wavesEngineeringbusiness.industryElectrical engineeringElectric generatorFerritePermanent magnet synchronous generatorAC powerSettore ING-IND/32 - Convertitori Macchine E Azionamenti Elettricilaw.inventionlawMagnettubular linear permanent magnet generator prototype simulationFerrite (magnet)businessAxial symmetryExcitation
researchProduct

Circulating miR-22, miR-24 and miR-34a as Novel Predictive Biomarkers to Pemetrexed-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

2013

Pemetrexed has been widely used in patients with advanced non-small cell lung cancer (NSCLC). The clinical relevance of polymorphisms of folate pathway genes for pemetrexed metabolism have not been fully elucidated yet. The aim of this study was to evaluate the expression levels of circulating miR-22, miR-24, and miR-34a, possibly involved in folate pathway, in NSCLC patients treated with pemetrexed compared with healthy controls and to investigate their impact on patient clinical outcomes. A total of 22 consecutive patients with advanced NSCLC, treated with pemetrexed-based chemotherapy and 27 age and sex matched healthy controls were included in this preliminary analysis. miR-22, miR-24, …

MaleGuanineSettore MED/06 - Oncologia MedicaPemetrexedMiddle AgedNeoplastic Cells CirculatingPrognosisBiomarkers PharmacologicalNon-Small Cell Lung CancerGene Expression Regulation NeoplasticMicroRNAsGlutamatesCarcinoma Non-Small-Cell LungBiomarkers TumorNon-Small Cell Lung Cancer; BiomarkersHumansFemaleBiomarkersAgedNeoplasm Staging
researchProduct

Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy

2015

This Report intends to estimate the total number of people still alive in 2010 after cancer diagnosis in Italy, regardless of the time since diagnosis, and to project these estimates to 2015. This study is also aimed to estimate the number of already cured cancer patients, whose mortality rates have become undistinguishable from that of the general population of the same age and sex.The study took advantage of the information from the AIRTUM database, which included 29 Cancer Registries (covering 21 million people, 35% of the Italian population). A total of 1,624,533 cancer cases diagnosed between 1976 and 2009 contributed to the study. For each registry, the observed prevalence was calcula…

Aged 80 and overMaleMedicine (all)Aged; Aged 80 and over; Female; Humans; Italy; Male; Middle Aged; Neoplasms; Prevalence; Registries; Survival RateSocio-culturaleMiddle AgedSettore MED/42 - Igiene Generale E ApplicataSurvival RateItalyNeoplasms80 and overPrevalenceHumanscancer prevalence cancer incidence cancer in ItalyFemaleRegistriesAged
researchProduct

1535P Exploring the dynamic crosstalk between immune system and genetics in a cohort of 116 completely resected gastrointestinal stromal tumors (GIST…

2021

Crosstalk (biology)Immune systemOncologybusiness.industryCohortmedicineCancer researchGastrointestinal stromal tumors (GISTs)Hematologymedicine.diseasebusinessAnnals of Oncology
researchProduct

162P Prevalence and spectrum analysis of germline BRCA1 and BRCA2 variants of unclear significance in HBOC Syndrome: Decoding the mysterious signals …

2021

GeneticsOncologybusiness.industryHBOC SyndromeMedicineHematologySpectrum analysisbusinessGenomeGermlineDecoding methodsAnnals of Oncology
researchProduct

Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)…

2021

Most anticancer molecules are administered in body-size-based dosing schedules, bringing up unsolved issues regarding pharmacokinetic data in heavy patients. The worldwide spread of obesity has not been matched by improved methods and strategies for tailored drug dosage in this population. The weight or body surface area (BSA)-based approaches may fail to fully reflect the complexity of the anthropometric features besides obesity in cancer patients suffering from sarcopenia. Likewise, there is a lack of pharmacokinetic data on obese patients for the majority of chemotherapeutic agents as well as for new target drugs and immunotherapy. Therefore, although the available findings point to the …

obesityCancer Researchmedicine.medical_specialtypharmacokinetic parametersConsensusBSAcancer drug dosingPopulationchemotherapy doseAntineoplastic AgentsReviewOverweightNODosing schedulesNeoplasmsPhysiciansInternal medicineHumansMedicineDosingLS4_3educationBody surface areaeducation.field_of_studybusiness.industryCancerCytotoxic chemotherapymedicine.diseaseOncologyBSA; cancer drug dosing; chemotherapy dose; obesity; pharmacokinetic parametersPosition paperBSA; cancer drug dosing; chemotherapy dose; obesity; pharmacokinetic parameters; Consensus; Humans; Obesity; Antineoplastic Agents; Neoplasms; Physiciansmedicine.symptombusinessESMO Open
researchProduct

p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospect…

2002

p53 gene alterations are among the most common events observed in colorectal cancer,and are accompanied frequently by DNA aneuploidy and high proliferative activity. The prognostic significance of such mutations remains controversial. We prospectively evaluated the prognostic significance of p53 mutations, DNA-ploidy, and S phase fraction (SPF) in a consecutive series of 160 colorectal cancer patients (median follow-up 71 months). Tumor DNA was screened for p53 mutations by PCR/single-strand conformational polymorphism/sequencing. DNA-ploidy and SPF were assessed by DNA flow cytometry. p53 mutations were detected in 68 of 160 (42.5%) cases. In 56% (38 of 68) of these, p53 mutations were fou…

MaleSettore MED/06 - Oncologia Medicaprotein p53S PhaseBiomarkers TumorHumansProspective StudiesCodonAgedPloidiesPolymorphism GeneticDNA NeoplasmExonsDNAMiddle AgedGenes p53PrognosisSurvival AnalysisProtein Structure TertiaryItalyMultivariate AnalysisMutationFemaleCarrier ProteinsColorectal NeoplasmsFollow-Up Studies
researchProduct

P07.02 Detection of Molecular Residual Disease (MRD) using ctDNA in NSCLC: A Systematic Review and Meta-Analysis

2021

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineMeta-analysismedicineDiseaseResidualbusinessJournal of Thoracic Oncology
researchProduct

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As and BTN3A1 in patients with metastatic gastrointestinal stromal tumours (mGISTs)

2019

Abstract Background Gastrointestinal stromal tumours (GISTs) account for 1% of all primary gastrointestinal cancers. In cancer, suppressive immune checkpoints, including butyrophilin sub-family 3A/CD277 receptors (BTN3A), programmed death protein (PD-1) and its ligand PD-L1, are often hyper-activated to ensure an effective evasion of tumor cells from immune surveillance. Since recent studies showed that PD-1 and PD-L1 expression in cancer may be an important prognostic factor, the aim of our study was to investigate if soluble forms of inhibitory immune checkpoints can help predict survival in metastatic GIST patients. Methods Using specific homemade ELISA assays not yet commercially availa…

Oncologymedicine.medical_specialtybiologybusiness.industryCancerImatinibHematologymedicine.diseaseLog-rank testImatinib mesylateOncologyInternal medicinePD-L1biology.proteinBiomarker (medicine)MedicineGastrointestinal cancerbusinessSurvival analysismedicine.drugAnnals of Oncology
researchProduct

P48.10 Chemo-Immunotherapy in the Frontline of Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Indirect Comparisons

2021

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineMedicinebusinessExtensive-stage small cell lung cancerChemo immunotherapyJournal of Thoracic Oncology
researchProduct

Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel …

2021

Background Hereditary breast cancer (BC), ovarian cancer (OC), and pancreatic cancer (PC) are the major BRCA-associated tumours. However, some BRCA1/2-wild-type (wt) patients with a strong personal and/or family history of cancer need a further genetic testing through a multi-gene panel containing other high- and moderate-risk susceptibility genes. Patients and methods Our study was aimed to assess if some BC, OC, or PC patients should be offered multi-gene panel testing, based on well-defined criteria concerning their personal and/or family history of cancer, such as earliness of cancer onset, occurrence of multiple tumours, or presence of at least two or more affected first-degree relativ…

OncologyCancer Researchmedicine.medical_specialtySettore MED/06 - Oncologia MedicaPALB2pancreatic cancerBreast NeoplasmsBreast cancerbreast cancerMUTYHInternal medicinePancreatic cancerMedicineHumansGenetic Predisposition to DiseaseGenetic TestingFamily historyCHEK2Original ResearchGenetic testingOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryBRCA1 ProteinCancermedicine.diseasePancreatic Neoplasmsovarian cancerOncologymulti-gene panel testingFemalegermline pathogenic variantsbusiness
researchProduct

Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study

2017

Oncologymedicine.medical_specialty010405 organic chemistrybusiness.industrySettore MED/06 - Oncologia MedicabREast cancer In elDerly patiEntsHematology010402 general chemistrymedicine.disease01 natural sciencesMetastatic breast cancer0104 chemical sciencesBreast cancerOncologyInternal medicinemedicinebusinessNab-paclitaxel
researchProduct

CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS.

2016

Background. Essential thrombocythemia (ET) and primary myelofibrosis (MF) are myeloproliferative neoplasms characterized by the overproduction of mature cells such as platelets (ET) or early bone marrow fibrosis due to scarring induced by highly proliferating myeloid progenitors and pathological stimulation of local fibroblasts (MF). Somatic mutations in CALR gene have recently identified in the majority of JAK2-V617F and MPL negative ET and MF patients. In this study we evaluated the frequency and type of CALR mutations and their clinical and hematological features. Methods. A total of 54 patients, 29 ET and 25 MF patient, was included in this study. All patients were JAK2 V617F and MPL ne…

JAK2 V617FJAK2 V617F; MPL negativeMPL negative
researchProduct

A non common BRAF mutation c1799-1801 delTGA identified in sporadic colon rectal cancer of sicilian patients

2010

Anthracycline has been shown to induce heart failure. To monitor this toxic damage, echocardiographic parameters of left ventricular (LV) systolic function are usually used. Aim of this study was to evaluate in lymphoma’s patients the reliability of echocardiographic data in comparison with a LV systo-diastolic parameter function: the Tei index.

BRAF mutation sicilian patients
researchProduct

Corrections to “Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?”

2017

Nessuno

0301 basic medicineOncologymedicine.medical_specialtyCetuximabbusiness.industryColorectal cancerHematologymedicine.disease03 medical and health sciences030104 developmental biologyAcquired resistanceOncologyInternal medicinemedicinebusinessmedicine.drugAnnals of Oncology
researchProduct

EGFR CELL EXPRESSION IN BLADDER WASHINGS AS A RISK MARKER TOOL IN NON MUSCLE-INVASIVE BLADDER CANCER. PRELIMINARY EXPERIENCE

2017

EGFR bladder cancer T1HG cystectomySettore MED/24 - Urologia
researchProduct

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE?

2019

MYELOPROLIFERATIVE NEOPLASMSMESENCHYMAL STEM CELLS
researchProduct

Biological characterization of laryngeal squamous-cell carcinoma

1996

The traditional prognostic factors, including stage of disease and tumour grade, have shown a limited prognostic significance and an inability to predict clinical response to specific treatment in patients with laryngeal squamous-cell carcinoma. More recent data suggest that cell kinetics indices, DNA-ploidy, lysosomal cysteine proteinase expression and genetic changes of both tumour suppressor genes and proto-oncogenes may be considered as reliable and reproducible indicators of biological aggressiveness in these patients. Moreover, the frequency of different genetic alterations suggests that several pathways are involved in the genesis of these neoplasias and, in particular, it is very pr…

Genes rasChromosomes Human Pair 11Settore BIO/14 - FarmacologiaHumansDNA NeoplasmFlow CytometryGenes p53Laryngeal NeoplasmsLaryngeal squamous-cell carcinomaCell Division
researchProduct

Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer.

2006

000
researchProduct

Safety of high doses of somatostatin analogs in well differentiated NENs in elderly

2019

Abstract Background Neuroendocrine neoplasms (NENs) are a group of heterogeneous neoplasms which can be treated with different therapies: in well differentiated (WD) NENs analogs of somatostatin (SSA) can be used considering their proved antineoplastic and antisecretory effects. This is a multicenter study to investigate the safety of high doses (HDD) analogs of somatostatin (SSA) in WD NENs with particular attention for patients over 70 years of age. Methods We collected clinical data from 13 Italian NENs dedicated Units. Patients with WD NENs, in progression on previous treatments, included SSA, and subsequently treated with HDD-SSA, were considered. Results 170 pts were included: 61.76% …

medicine.medical_specialtyGastrinomabusiness.industryHematologyNeuroendocrine tumorsmedicine.diseaseGastroenterologyZollinger-Ellison syndromeSteatorrheaOncologyInternal medicineCholecystitisMedicinemedicine.symptombusinessInsulinomaCarcinoid syndromeMalignant Carcinoid SyndromeAnnals of Oncology
researchProduct

COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the …

2021

High mortality rates in elderly patients or in those with underlying chronic illnesses and/or a compromised immune system is a peculiar feature of COVID-19 infection. The possible coexistence of a cancer and COVID-19 infection in the same individual prompted concerns regarding their synergistic effect on prognosis. In order to balance patients’ needs with the risks related to the infection, the question oncologists have asked from the beginning of the first wave of the pandemic has been: ‘how can we deal with COVID-19 infection in cancer patients?’ In pursuing its mission, the Associazione Italiana Oncologia Medica (AIOM) has made every possible effort to support cancer patients, health car…

Cancer Research2019-20 coronavirus outbreakmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)FAVO Federazione delle Associazioni di Volontariato in OncologiaReviewWHO World Health OrganizationCIPOMO Italian College of Primary Hospital Medical OncologistsSICO Società Italiana di Chirurgia OncologicaMedicalNeoplasmsHealth carePandemicMedicinecancerCentral Venous CathetersHumansFNOPI Federazione Nazionale Ordini Professioni InfermieristicheSocieties MedicalAIRO Associazione Italiana Radioterapia e Oncologia clinicaOncologistsClinical Trials as Topictreatmentbusiness.industryHigh mortalityAIOM Associazione Italiana di Oncologia medicaCancerNeoplasms therapyAIOM; cancer; COVID-19; treatment; vaccination; Central Venous Catheters; Clinical Trials as Topic; Humans; Influenza Vaccines; Oncologists; Practice Guidelines as Topic; COVID-19; COVID-19 Vaccines; Neoplasms; Societies MedicalCOVID-19medicine.diseasevaccinationCOMU College of University Medical OncologistsOncologyInfluenza VaccinesFamily medicineFOCE ConFederazione degli Oncologi Cardiologi e EmatologiPractice Guidelines as TopicESMO European Society for Medical OncologybusinessSocietiesSIPO Società Italiana di Psico-OncologiaAIOMESMO open
researchProduct

The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships

2007

Background: Insulin receptor substrate 1 (IRS-1) is a signaling molecule that exerts a key role in mediating cross talk between estrogen receptor a (ERa) and insulin-like growth factor 1 (IGF-1) in breast cancer cells. Previously, we demonstrated that a fraction of IRS-1 binds ERa, translocates to the nucleus, and modulates ERa-dependent transcription at estrogen response elements (ERE). Here, we studied structure-function relationships of the ER-a:IRS-1 complex under IGF-1 and/or estradiol (E 2 ) stimulation. Materials and methods: ERa and IRS-1 deletion mutants were used to analyze structural and functional ERα/IRS-1 interactions. IRS-1 binding to ERE and IRS-1 role in ERa-dependent ERE t…

medicine.medical_specialtyInsulin Receptor Substrate ProteinsActive Transport Cell NucleusEstrogen receptorRepressorBreast NeoplasmsBiologyStructure-Activity Relationshipestrogen receptor alpha (ERa) Insulin receptor substrate 1 (IRS-1) breast cancerCell Line TumorInternal medicineCoactivatormedicineHumansInsulin-Like Growth Factor IReceptors InterferonEstradiolEstrogen Receptor alphaHematologyDNA-binding domainPhosphoproteinsPeptide FragmentsReceptor InsulinProtein Structure TertiaryCell biologyIRS1Repressor ProteinsPleckstrin homology domainEndocrinologyOncologyInsulin Receptor Substrate ProteinsFemaleChromatin immunoprecipitationProtein BindingAnnals of Oncology
researchProduct

Utility of laser microdissection and pressure catapulting in the diagnosis of non small cell lung cancer: Preliminary data

2014

Background: There are controversies about the adequacy of tumor tissue sample on which the sequencing of molecular diagnosis could be performed to achieve the targeted-therapy on lung cancer. The aim of this study is to demonstrate the role of the Laser Microdissection Pressure Catapulting (LMPC) technique to obtain adequate tumor tissue sample for the molecular analysis of gene mutations in the target therapy of lung cancer. Findings: From a consecutive series of 24 patients with a diagnosis of locally-advanced or metastatic Non Small Cell Lung Cancer (NSCLC), we performed 29 diagnostic procedures using the system of LMPC, to obtain an homogeneous samples where it was possible to run the s…

Lung cancer bronchoscopy Laser Microdissection Pressure Catapulting molecular analysis.
researchProduct

Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1alpha in human colorectal cancer.

2007

researchProduct

HIGH GRADE GLIOMAS AND DIPG

2014

OncologyCancer Researchmedicine.medical_specialtybusiness.industry03 medical and health sciencesAbstracts0302 clinical medicineText miningOncology030220 oncology & carcinogenesisInternal medicinemedicineNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Carotid endarterectomy in heart transplant patients

2005

AIM: The aim of this study was to determine the clinical outcome of carotid endarterectomy in heart transplant recipients and morphologic features of atherosclerotic plaques removed during operation. METHODS: Between April 1993 and October 2001 5 heart transplant patients with symptomatic carotid stenosis >70% underwent carotid endarterectomy with regional anesthesia, including a staged bilateral procedure in one patient. Cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol were evaluated in each patient. The plaques ( n=6) underwent histologic analysis after carotid endarterectomy. Carotid artery duplex imaging was added to the routine postoperative evaluation. RESULTS: Carotid pla…

MaleUltrasonography Doppler Duplexcarotid plaqueMiddle Agedendarterectomy carotidheart transplantationSettore MED/22 - Chirurgia Vascolarecarotid stenosiatherosclerositreatment outcomeHumansCarotid StenosisFemaleCardiomyopathiescarotid endarterectomyAgedFollow-Up StudiesRetrospective Studies
researchProduct

166P Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes

2021

Oncologybusiness.industryCancer researchMedicineHematologybusinessGeneAnnals of Oncology
researchProduct

215P Analysis of spatial heterogeneity of responses in metastatic sites with nivolumab in renal cell carcinoma

2020

Oncologybusiness.industryRenal cell carcinomaCancer researchMedicineHematologyNivolumabbusinessmedicine.diseaseSpatial heterogeneityAnnals of Oncology
researchProduct

Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma

2000

A consecutive series of 63 untreated patients undergoing surgical resection for stage I-IV gastric adenocarcinomas (GCs) has been prospectively studied. Our purpose was to analyze the predictive relevance of DNA ploidy, S-phase fraction (SPF), and tissue levels of lysosomal proteinases cathepsin D (CD), cathepsin B (CB), cathepsin L (CL), and urokinase-type plasminogen activator (uPA) and that of the intracellular cysteine proteinase inhibitor stefin A on clinical outcome. All of the patients taking part in this study were followed up for a median of 73 months. DNA aneuploidy was present in 71% of the cases (45/63), whereas 9% of these (4/45) showed multiclonality. Both DNA ploidy and SPF w…

AdultMaleTime FactorsAdenocarcinomaS PhasePredictive Value of TestsStomach NeoplasmsBiomarkers TumorAspartic Acid EndopeptidasesHumansNeoplasm Invasivenesshumancell cycle S phase; disease association; female; histopathology; human; lymph node metastasisAgedProbabilityPloidieslymph node metastasisdisease associationSerine EndopeptidasesDNA NeoplasmMiddle AgedPrognosisSurvival AnalysisCysteine Endopeptidasescell cycle S phaseLymphatic MetastasishistopathologyFemaleFollow-Up Studies
researchProduct

247P Population-based testing for hereditary breast and ovarian cancer in a cohort of 1,346 patients from Southern Italy (Sicily): When historical ba…

2020

Oncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineCohortMedicineHematologyPopulation basedbusinessOvarian cancermedicine.diseaseAnnals of Oncology
researchProduct

The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-an…

2016

OncologySurgical resectionmedicine.medical_specialtybusiness.industryColorectal cancerHematologymedicine.diseasemedicine.disease_causeMetastasisOncologyMeta-analysisInternal medicineMedicineIn patientKRASbusinessAnnals of Oncology
researchProduct

Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children

2006

There is increasing interest in the potential influence of fetal and early life conditions on childhood wheezing.To investigate the associations between maternal complications and procedures in pregnancy and at birth and the risk of various wheezing phenotypes in young children.We studied 15,609 children, aged 6-7 yr, enrolled in a population-based study. Standardized questionnaires were completed by the children's mothers.Of the children, 9.5% (1,478) had transient early wheezing, 5.4% (884) had persistent wheezing, and 6.1% (948) had late-onset wheezing. Maternal hypertension or preeclampsia was associated with an increased risk of all three wheezing phenotypes (for transient early wheezi…

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyPopulationPerinatalCritical Care and Intensive Care Medicineasthma; perinatal; programmingPregnancyRisk FactorsIntensive careAsthma; Perinatal; Programming; Child; Female; Humans; Pregnancy; Respiratory Sounds; Risk Factors; Pregnancy Complications; Medicine (all); Pulmonary and Respiratory Medicine; Critical Care and Intensive Care MedicineMaternal hypertensionMedicineHumansRespiratory Sounds; Pregnancy Complications; Risk Factors; Humans; Child; Female; PregnancyRespiratory soundseducationChildAsthmaRespiratory SoundsPregnancyeducation.field_of_studymedicine.diagnostic_testbusiness.industryRisk FactorMedicine (all)Odds ratiomedicine.diseasePregnancy ComplicationAsthmaPregnancy ComplicationsProgrammingGestationFemaleRespiratory SoundbusinessHuman
researchProduct

Omics approaches to elucidate the molecular physiology of lantibiotc NAI-107 production in Microbispora ATCC-PTA-5024

2015

Microbispora NAI-107 2D-DIGESettore BIO/19 - Microbiologia Generale
researchProduct

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing

2020

Abstract Background Few data are reported in the literature about the outcome of patients with severe extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) infections treated with ceftolozane/tazobactam (C/T), in empiric or definitive therapy. Methods A multicenter retrospective study was performed in Italy (June 2016–June 2019). Successful clinical outcome was defined as complete resolution of clinical signs/symptoms related to ESBL-E infection and lack of microbiological evidence of infection. The primary end point was to identify predictors of clinical failure of C/T therapy. Results C/T treatment was documented in 153 patients: pneumonia was the most common diagnosis (n = 46…

medicine.medical_specialtyceftolozane/tazobactammedicine.medical_treatmentCRRTTazobactamEnterobacteralesEnterobacteraleInternal medicineCRRT; ESBL; Enterobacterales; ceftolozane/tazobactam; septic shockMajor ArticlemedicineClinical endpointRenal replacement therapybusiness.industrySeptic shockRetrospective cohort studyOdds ratiomedicine.diseaseCeftolozane/tazobactam; CRRT; Enterobacterales; ESBL; Septic shockAcademicSubjects/MED00290Infectious DiseasesOncologyESBLseptic shockCeftolozanebusinessEmpiric therapymedicine.drugOpen forum infectious diseases
researchProduct

1818P Body mass index (BMI) is not a cancer risk factor for BRCA1/2 carriers: A systematic review and meta-analysis of case-control studies

2021

Oncologymedicine.medical_specialtyText miningOncologybusiness.industryMeta-analysisInternal medicineCase-control studymedicineHematologyCancer risk factorbusinessBody mass indexAnnals of Oncology
researchProduct

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

2018

Background: Chemotherapy plus 1-year trastuzumab is the standard adjuvant treatment of HER2-positive breast cancer. The efficacy of less extended trastuzumab exposure is under investigation. The short-HER study was aimed to assess the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy. Patients and methods: HER2-positive breast cancer patients with node-positive or, if node negative, with at least one risk factor (pT>2 cm, G3, lympho-vascular invasion, Ki-67 > 20%, age 35 years, or hormone receptor negativity) were randomly assigned to receive sequential anthracycline-taxane combinations plus 1-year trastuzumab (arm A, long) or plus 9 weeks tra…

OncologyTime FactorsAdjuvant Breast cancer Cardiac safety De-escalated treatment TrastuzumabSettore MED/06 - Oncologia MedicaReceptor ErbB-2medicine.medical_treatmentAnthracycline030204 cardiovascular system & hematologyBreast cancerAntineoplastic Agents ImmunologicalErbB-20302 clinical medicineTrastuzumabAntineoplastic Combined Chemotherapy ProtocolsClinical endpointAnthracyclinesskin and connective tissue diseasesAdjuvantMastectomyAdjuvant; Breast cancer; Cardiac safety; De-escalated treatment; Trastuzumab;Hazard ratioHematologyMiddle AgedChemotherapy regimenBridged-Ring CompoundImmunologicalLocalOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisFemaleTaxoidsTrastuzumab adjuvant breast cancer cardiac safety de-escalated treatmentBreast NeoplasmMastectomyHumanReceptormedicine.drugAdultBridged-Ring Compoundsmedicine.medical_specialtyTime FactorSocio-culturaleBreast NeoplasmsAntineoplastic AgentsDe-escalated treatmentDisease-Free SurvivalDrug Administration Schedule03 medical and health sciencesBreast cancerTaxoidInternal medicinemedicineHumansChemotherapyRisk factorAgedNeoplasm StagingChemotherapyAntineoplastic Combined Chemotherapy ProtocolCardiac safetybusiness.industryTrastuzumabAdjuvant; Breast cancer; Cardiac safety; De-escalated treatment; Trastuzumab; Hematology; Oncologymedicine.diseaseCardiotoxicityNeoplasm RecurrenceNeoplasm Recurrence LocalbusinessAnnals of Oncology
researchProduct

5-Fluorouracil plus interferon α-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: A multicentric randomized study

1998

Biochemical modulation is one of the most interesting fields in cancer chemotherapy. Interferon-alpha (IFNalpha) is a cytokine that is able to influence the pharmacodynamics of 5-fluorouracil (5FU) through a number of mechanisms. With the aim of confirming some data emerging from the literature, we initiated a multicentric randomized study comparing the combination of 5FU and IFNalpha-2a with 5FU alone in the treatment of advanced or metastatic colon cancer. A group of 205 colon cancer patients (104 in the 5FU arm and 101 in the 5FU + IFNapha-2a arm) were included in the final intention-to-treat analysis. Rectal cancers were not considered eligible. All patients had measurable disease, were…

MaleAntimetabolites AntineoplasticCancer Researchmedicine.medical_specialtyColorectal cancerAlpha interferonInterferon alpha-2GastroenterologyMetastasisInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansInterferon alfaAgedLeukopeniabusiness.industryStandard treatmentInterferon-alphaGeneral MedicineMiddle Agedmedicine.diseaseRecombinant ProteinsSurgeryOncologyFluorouracilColonic NeoplasmsFemaleFluorouracilmedicine.symptombusinessmedicine.drugJournal of Cancer Research and Clinical Oncology
researchProduct

Children with special health care needs attending emergency department in Italy: analysis of 3479 cases

2020

Abstract Background Although children with special health care needs (CSHCN) represent a minority of the population, they go through more hospitalizations, more admissions to the Emergency Department (ED), and receive a major number of medical prescriptions, in comparison to general pediatric population. Objectives of the study were to determine the reasons for admission to the ED in Italian CSHCN, and to describe the association between patient’s demographic data, clinical history, and health services requirements. Methods Ad hoc web site was created to collect retrospective data of 3479 visits of CSHCN to the ED in 58 Italian Hospitals. Results Seventy-two percent of patients admitted to …

MaleMetabolic diseaseHospitalization rateCongenital skeletal conditionHospitalization rateChildren with special health care needs; Congenital skeletal condition; Emergency department; Hospitalization rate; Isolated CNS malformation; Metabolic diseases; Multiple AED therapy; Neuromuscular diseases; Syndromic disorders; True isolated microcephaly0302 clinical medicineClinical historyMedicineChildeducation.field_of_studyNeuromuscular diseaseSettore MED/38Disabled ChildrenHospitalizationNeuromuscular diseasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAItalyChild PreschoolFemaleChildren with special health care needEmergency Service Hospitalmedicine.medical_specialtyAdolescentPopulationTriage CodeChildren with special health care needsSyndromic disordersChildren with special health care needs03 medical and health sciencesPharmacotherapy030225 pediatricsHumansMedical prescriptioneducationRetrospective StudiesHealth Services Needs and DemandSyndromic disorderEmergency departmentTrue isolated microcephalybusiness.industryResearchInfant NewbornInfantMetabolic diseases030208 emergency & critical care medicineEmergency departmentChildren with special health care needs Congenital skeletal conditionsEmergency department Hospitalization rate Isolated CNS malformation Metabolic diseases Multiple AED therapy Neuromuscular diseases Syndromic disorders True isolated microcephalyFamily medicineChronic DiseaseMultiple AED therapyIsolated CNS malformationbusinessFacilities and Services UtilizationItalian Journal of Pediatrics
researchProduct

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

2019

Alessio Cortellini,1,2 Katia Cannita,1 Alessandro Parisi,1,2 Paola Lanfiuti Baldi,1 Olga Venditti,1 Carla D’Orazio,1,2 Antonella Dal Mas,3 Giuseppe Calvisi,3 Aldo V Giordano,4 Vincenzo Vicentini,5 Roberto Vicentini,5 Lara Felicioni,6 Antonio Marchetti,7 Fiamma Buttitta,6 Antonio Russo,8 Corrado Ficorella1,2 1Medical Oncology, St Salvatore Hospital, University of L’Aquila, L’Aquila, Italy; 2Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy; 3Department of Pathology, St Salvatore Hospital L’Aquila, L’Aquila, Italy; 4Diagnostic and Interventional Radiology, St Salvatore Hos…

5-fluorouracil infusion; Bevacizumab; Clinical practice; Intensive chemotherapy regimen; Metastatic colorectal cancerintensive chemotherapy regimenmetastatic colorectal cancer intensive chemotherapy regimen bevacizumab clinical practice 5-fluorouracil infusionmetastatic colorectal cancer5-fluorouracil infusionbevacizumabOncoTargets and TherapyOriginal Researchclinical practiceOncoTargets and therapy
researchProduct

LncRNA H19, HOTAIR and MALAT1 as prognostic molecular biomarkers in GIST

2017

MALAT1OncologyGiSTbusiness.industryCancer researchMedicineHOTAIRHematologybusinessMolecular biomarkersAnnals of Oncology
researchProduct

20P Is evaluation of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutational status on circulating tumour DNA (ctD…

2021

Kinasebusiness.industryProtein subunitAlpha (ethology)HematologyMolecular biologychemistry.chemical_compoundOncologyPhosphatidylinositol 45-bisphosphatechemistryMutational statusMedicineLiquid biopsybusinessDNAAnnals of Oncology
researchProduct

Proteomics to elucidate the molecular physiology of Microbispora sp. ATCC-PTA-5024, the producer of NAI-107, a very promising lantibiotic

2015

The filamentous actinobacterium Microbispora sp. ATCC-PTA-5024 produces the lantibiotic NAI-107 (Maffioli et al., 2014), which is effective against multidrug-resistant Gram-positive pathogens (Jabés et al., 2011). In actinomycetes, the biosynthesis of antibiotics is generally elicited as a physiological response controlled by a complex regulatory network involving global regulators, playing pleiotropic roles, and pathway-specific regulators, which activate the biosynthesis of biologically active molecules (Bibb, 2005)

Microbispora sp. ATCC-PTA-5024 lantibiotic NAI-107 ProteomicsSettore BIO/19 - Microbiologia Generale
researchProduct

The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies

2021

The term liquid biopsy (LB) refers to the use of various biological fluids as a surrogate for neoplastic tissue to achieve information for diagnostic, prognostic and predictive purposes. In the current clinical practice, LB is used for the identification of driver mutations in circulating tumor DNA derived from both tumor tissue and circulating neoplastic cells. As suggested by a growing body of evidence, however, there are several clinical settings where biological samples other than tissue could be used in the routine practice to identify potentially predictive biomarkers of either response or resistance to targeted treatments. New applications are emerging as useful clinical tools, and o…

Societies ScientificCancer ResearchContext (language use)ReviewNeoplastic CellsBioinformaticsCirculating tumor cellCirculatingBiomarkers TumorMedicineHumansDigital polymerase chain reactionLiquid biopsycfDNAcirculating tumor DNAcfDNA; circulating cell-free DNA; circulating tumor DNA; ctDNA; digital PCR; liquid biopsy; next-generation sequencing; real-time PCRTumorCirculating Neoplastic Cellsliquid biopsybusiness.industrydigital PCRScientificctDNAcirculating cell-free DNANeoplastic Cells CirculatingCirculating Cell-Free DNAcfDNA; circulating cell-free DNA; circulating tumor DNA; ctDNA; digital PCR; liquid biopsy; next-generation sequencing; real-time PCR; Biomarkers Tumor; Humans; Italy; Liquid Biopsy; Neoplastic Cells Circulating; Societies ScientificOncologyItalyCirculating tumor DNAPosition papernext-generation sequencingSocietiesbusinessreal-time PCRBiomarkersHuman
researchProduct

Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-l…

2011

acromegaly Janus Kinase
researchProduct

167P Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer

2021

Oncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineMedicineIn patientHematologybusinessBilateral breast cancerMulti geneAnnals of Oncology
researchProduct

P2.04-11 An IL-8/IFN-gammma/NLR Plasma Score to Predict Nivolumab Efficacy in Patients with NSCLC

2018

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineMedicineIn patientInterleukin 8NivolumabbusinessJournal of Thoracic Oncology
researchProduct

Supplementary Material for: Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Varia…

2017

Objectives: The rapid fatality of pancreatic cancer is, in large part, the result of diagnosis at an advanced stage in the majority of patients. Identification of individuals at risk of developing pancreatic adenocarcinoma would be useful to improve the prognosis of this disease. There is presently no biological or genetic indicator allowing the detection of patients at risk. Our main goal was to identify copy number variants (CNVs) common to all patients with sporadic pancreatic cancer. Methods: We analyzed gene CNVs in leukocyte DNA from 31 patients with sporadic pancreatic adenocarcinoma and from 93 matched controls. Genotyping was performed with the use of the GeneChip Human Mapping 500…

researchProduct